Hepatitis C and B virus infections in hepatocellular carcinoma: Analysis of direct detection of viral genome in paraffin embedded tissues

Cancer

Volumn 77, Issue 9, 1996, Pages 1787-1791

  Edamoto, Yoshihiro ^a,b   Tani, Masayoshi ^b   Kurata, Takeshi ^a   Abe, Kenji ^a  

^a NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^b NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

Author keywords

formalin fixed paraffin embedded tissue; hepatitis B virus DNA; hepatitis C virus RNA; hepatocellular carcinoma; Japanese; PCR

Indexed keywords

ARTICLE; CANCER RECURRENCE; DNA DETERMINATION; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN TISSUE; LIVER CELL CARCINOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; TISSUE SECTION; VIRUS DETECTION; VIRUS GENOME; VIRUS INFECTION;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, HEPATOCELLULAR; DNA, VIRAL; FEMALE; FIXATIVES; FORMALDEHYDE; GENOME, VIRAL; GENOTYPE; HEPACIVIRUS; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C ANTIBODIES; HUMANS; JAPAN; LIVER NEOPLASMS; MALE; MIDDLE AGED; PARAFFIN EMBEDDING; POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDIES; RNA, VIRAL; SEROEPIDEMIOLOGIC STUDIES; TRANSCRIPTION, GENETIC;

EID: 0029915093     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19960501)77:9<1787::AID-CNCR5>3.0.CO;2-9     Document Type: Article

References (19)

1. Kiyosawa K, Sodeyama T, Tanaka E, Gibo Y, Yoshizawa K, Nakano Y, et al. Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: analysis by detection of antibody to hepatitis C virus. Hepatology 1990;12:671-5.
2. Nishioka K, Watanabe J, Furuta S, Tanaka E, Iino S, Suzuki H, et al. A high prevalence of antibody to the hepatitis C virus in patients with hepatocellular carcinoma in Japan. Cancer 1991;67:429-33.
3. Tomimatsu M, Ishiguro N, Taniai M, Okuda H, Saito A, Obata H, et al. Hepatitis C virus antibody in patients with primary liver cancer (hepatocellular carcinoma, cholangiocarcinoma, and combined hepatocellular-cholangiocarcinoma) in Japan. Cancer 1993;72:683-8.
4. Takano S, Yokosuka O, Imazeki F, Tagawa M, Omata M. Incidence of hepatocellular carcinoma in chronic hepatitis B and C: a prospective study of 251 patients. Hepatology 1995;21:650-5.
5. Abe K, Tani M, Edamoto Y, Hayashi S, Saito T, Kurata T. Detection of hepatitis C virus genome in paraffin-embedded tissues by nested reverse transcription polymerase chain reaction. Int Hepatol Commun 1994;2:352-7.
6. Okamoto H, Sugiyama Y, Okada S, Kurai K, Akahane Y, Sugai Y, et al. Typing hepatitis C virus by polymerase chain reaction with type-specific primers: application to clinical surveys and tracing infectious sources. J Gen Virol 1992;37: 673-9.
7. Okamoto H, Tokita H, Sakamoto M, Horikita M, Kojima M, Iizuka H. et al. Characterization of the genomic sequence of type V (or 3a) hepatitis C virus isolates and PCR primers for specific detection. J Gen Virol 1993;74:2385-90.
8. Ruiz J, Sangro B, Cuende JI, Beloqui O, Riezu-Boj JI, Herrero JI, et al. Hepatitis B and C viral infections in patients with hepatocellular carcinoma. Hepatology 1992;16:637-41.
9. Colombo M, Kuo G, Choo QL, Donato MF, Del Ninno E, Tommasini MA, et al. Prevalence of antibodies to hepatitis C virus in Italian patients with hepatocellular carcinoma. Lancet 1989;2:1006-9.
10. Kew MC, Houghton M, Choo QL, Kuo G. Hepatitis C virus antibodies in southern African blacks with hepatocellular carcinoma. Lancet 1990;1:873-4.
11. Yu MC, Tong MJ, Coursaget P, Ross RK, Govindarajan S, Henderson BE. Prevalence of hepatitis B and C viral markers in black and white patients with hepatocellular carcinoma in the United States. J Natl Cancer Inst 1990;82:1038-41.
12. The Liver Cancer Study Group of Japan. Primary liver cancer in Japan. Ann Surg 1990;211:277-87.
13. Pozzato G, Moretti M, Franzin F, Croce LS, Tiribelli C, Masayu T, et al. Severity of liver disease with different hepatitis C viral clones. Lancet 1991;338:509.
14. Kanai K, Kako M, Okamoto H. HCV genotypes in chronic hepatitis C and response to interferon. Lancet 1992;339: 1543.
15. Nousbaum JB, Pol S, Nalpas B, Landais P, Berthelot P, Brechot C, et al. Hepatitis C virus type 1b (II) infection in France and Italy. Ann Intern Med 1995;122:161-8.
16. Kim JP, Linnen J, Wages J, Shih J, Nakatsuji Y, Fry K, et al. Identification of a new hepatitis virus (HGV) and its implication in post transfusion hepatitis. Hepatology 1995;22:218A.
17. Brechot C, Pourcel C, Louise A, Rain B, Tiollais P. Presence of integrated hepatitis B virus DNA sequence in cellular DNA of human hepatocellular carcinoma. Nature 1980;286:533-5.
18. Robinson WS. Hepadnaviruses and hepatocellular carcinoma (HCC). Cancer Detect Prevent 1989;14:245-52.
19. Chisari FV, Klopchin K, Moriyama T, Pasquinelli C, Dunsford HA, Sell S, et al. Molecular pathogenesis of hepatocellular carcinoma in hepatitis B virus transgenic mice. Cell 1989; 59:1145-56.